Roche is considering seeking accelerated approval for its experimental Alzheimer’s drug, trontinemab, following promising early results. Trontinemab is currently in Phase 2 testing and has shown significant potential in reducing amyloid levels in the brain. This approach has been previously a
MilliporeSigma, a prominent player in the life sciences sector, has launched a transformative $76 million investment dedicated to expanding its ADC (antibody-drug conjugates) manufacturing capabilities at its St. Louis, Missouri facility. This monumental investment encapsulates the extensive
LakeShore Biopharma Co., Ltd (NASDAQ: LSB), a prominent biopharmaceutical company, has successfully regained compliance with Nasdaq's minimum bid price requirement after experiencing non-compliance due to a prolonged period of its share price falling below $1.00. As of October 21, 2024, the
The recent FDA approval of Protega Pharmaceuticals Inc.'s ROXYBOND (oxycodone hydrochloride) immediate-release (IR) CII 10 mg tablet marks a significant milestone in managing severe pain where alternative treatments fall short. ROXYBOND 10 mg stands out as the first FDA-approved
In a significant advancement for International Process Plants (IPP), the Universal Glasteel Equipment (UGE) subsidiary has attained the American Society of Mechanical Engineers (ASME) 'R' Certificate for its facility in Eastover, South Carolina. This recent recognition permits IPP to
Kapoose Creek Bio, a biotechnology firm well-versed in AI-driven natural product drug discovery, has made a significant leap forward with its latest acquisition. The company has secured an exclusive license to the chemical informatics platform of Adapsyn Bioscience and acquired Adapsyn's drug
In the fast-evolving field of cellular biology, fluorescence imaging has emerged as a revolutionary tool for tracking cellular processes. With its ability to provide detailed and dynamic views of life on a microscopic scale, it has opened new paths for research and understanding, profoundly
Switzerland has established itself as a global leader in the biotech industry, making significant advancements in areas such as cancer treatment, immunotherapy, gene and cell therapy, and more. With a strong focus on personalized and precision medicine, the Swiss biotech sector thrives on
Rentschler Biopharma, a globally recognized Contract Development and Manufacturing Organization (CDMO), is making significant strides in the biomanufacturing landscape. The company's recent investments showcase its commitment to expanding cGMP capabilities and bolstering cell and gene therapy
Avandra, the largest federated network for de-identified medical image data, has emerged from stealth mode with a mission to transform how medical imaging is used for research and innovation. With the colossal task of harnessing over two trillion medical images worldwide, Avandra aims to build a
